Fact CheckerSign in

NCT05876130Recruiting

Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer

Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer: A Prospective Phase II Trial (POHIM_EM Trial)

Source: ClinicalTrials.gov · Last updated 12 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To investigate the non-inferiority of disease-free survival in women who received hypofractionated intensity-modulated whole pelvic radiation therapy (2.5 Gy x 16 fractions) after curative surgery for stage III endometrial cancer.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
92 (estimated)
First submitted
16 May 2023
Start date
1 Nov 2022
Primary completion date
31 Dec 2031
Lead sponsor
Samsung Medical Center
NCT number
NCT05876130

What you commit to

  • Study type: Interventional
  • Planned participants: 92
  • From 1 Nov 2022 to the primary completion date, 31 Dec 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous history of pelvic radiotherapy
  • previous history of other carcinoma except for thyroid cancer, skin cancer, and endometrial cancer

Other illness

  • severe and unstable medical condition

Other

  • presence of distant metastasis

Who the study is looking for

  • histologically confirmed endometrioid type endometrial cancer
  • completion of hysterectomy and surgical staging
  • pathologically confirmed FIGO stage III
  • ECOG performance status 0 or 1
  • adjuvant chemotherapy was done or planned

Age in the registry: 20 years to 80 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.